Join to View Full Profile
2050 Kenny RdColumbus, OH 43221
Phone+1 614-293-5066
Fax+1 614-293-9449
Dr. Hasanov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Merve Hasanov is an oncologist specializing in melanoma, based in Columbus, OH. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center at Houston/M D Anderson Cancer Center. Dr. Hasanov is currently an Assistant Professor at The Ohio State University Comprehensive Cancer Center. Her research has resulted in multiple publications, including studies on melanoma brain metastasis and diabetes as a risk factor for pancreatic lesions, with some works being cited by other publications.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2020 - 2023- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2017 - 2020
Hacettepe University FOMClass of 2014
Certifications & Licensure
OH State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis.Swaminathan Kumar, Meredith S Pelster, Merve Hasanov, Renato A Guerrieri, Courtney W Hudgens
Acta Neuropathologica Communications. 2025-04-15 - Melanoma Brain Metastasis: Biology and Therapeutic Advances.Merve Hasanov, Yusuf Acikgoz, Michael A Davies
Hematology/oncology Clinics of North America. 2024-10-01 - 1 citationsNew-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort study.Seyda Baydogan, Chirayu Mohindroo, Merve Hasanov, Maria F Montiel, Pompeyo Quesada
Endoscopic Ultrasound. 2024-04-10
Press Mentions
New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant MetastasisApril 25th, 2025- AACR 2025: Colon Cancer Risk Reduction, Predicting Melanoma Spread and New Drug Therapies Among Ohio State FindingsApril 23rd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
